X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14571) 14571
Publication (1096) 1096
Book Review (371) 371
Newspaper Article (221) 221
Newsletter (206) 206
Magazine Article (154) 154
Book Chapter (101) 101
Book / eBook (64) 64
Conference Proceeding (34) 34
Dissertation (25) 25
Trade Publication Article (17) 17
Web Resource (13) 13
Government Document (7) 7
Reference (7) 7
Report (4) 4
Transcript (4) 4
Presentation (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11607) 11607
osteoporosis (11590) 11590
female (9379) 9379
index medicus (6342) 6342
aged (6089) 6089
middle aged (5952) 5952
male (4730) 4730
risk factors (4670) 4670
bone density (4357) 4357
fractures (4257) 4257
endocrinology & metabolism (4219) 4219
postmenopausal women (4000) 4000
orthopedics (2888) 2888
adult (2818) 2818
bone-mineral density (2719) 2719
medicine & public health (2715) 2715
aged, 80 and over (2654) 2654
women (2654) 2654
bones (2539) 2539
osteoporosis - complications (2493) 2493
osteoporosis, postmenopausal - complications (2330) 2330
rheumatology (2288) 2288
density (2279) 2279
bone mineral density (2170) 2170
research (2065) 2065
health aspects (2059) 2059
risk (1931) 1931
endocrinology (1929) 1929
care and treatment (1789) 1789
complications and side effects (1704) 1704
hip fracture (1691) 1691
osteoporosis - drug therapy (1646) 1646
mineral density (1609) 1609
bone density conservation agents - therapeutic use (1602) 1602
bone density - drug effects (1535) 1535
fractures, bone - etiology (1531) 1531
absorptiometry, photon (1506) 1506
osteoporosis - etiology (1477) 1477
prevention (1465) 1465
animals (1356) 1356
bone density - physiology (1323) 1323
osteoporosis, postmenopausal - drug therapy (1309) 1309
analysis (1264) 1264
diagnosis (1183) 1183
fracture (1168) 1168
postmenopausal osteoporosis (1149) 1149
bisphosphonates (1144) 1144
drug therapy (1117) 1117
bone (1105) 1105
medicine, general & internal (1083) 1083
diphosphonates - therapeutic use (1077) 1077
prevalence (1070) 1070
osteoporosis - physiopathology (1027) 1027
alendronate (1017) 1017
vitamin d (1010) 1010
osteoporosis - epidemiology (985) 985
vertebral fractures (975) 975
menopause (970) 970
men (962) 962
fractures, bone - prevention & control (943) 943
treatment outcome (935) 935
osteoporosis - diagnosis (916) 916
osteoporosis - prevention & control (915) 915
spinal fractures - etiology (889) 889
epidemiology (882) 882
prospective studies (833) 833
risk assessment (825) 825
physiological aspects (817) 817
therapy (816) 816
cross-sectional studies (808) 808
hormone replacement therapy (799) 799
calcium (797) 797
retrospective studies (757) 757
follow-up studies (753) 753
medicine (753) 753
incidence (751) 751
risk-factors (751) 751
age factors (742) 742
age (740) 740
radiography (735) 735
fracture risk (730) 730
mass (728) 728
internal medicine (718) 718
surgery (716) 716
spine (713) 713
mortality (712) 712
metabolism (688) 688
osteopenia (686) 686
older people (685) 685
disease (680) 680
fractures, bone - epidemiology (663) 663
case-control studies (661) 661
body mass index (653) 653
osteoporosis, postmenopausal - physiopathology (651) 651
vertebral fracture (651) 651
gynecology (645) 645
bone density conservation agents - adverse effects (637) 637
zoledronic acid (634) 634
adolescent (631) 631
usage (631) 631
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (43) 43
Online Resources - Online (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
New College (Ivey) - Stacks (6) 6
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Providence Healthcare - Stacks (2) 2
Lakeridge Health Sciences - Oshawa (1) 1
OISE - Stacks (1) 1
Providence Healthcare - Reference (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14653) 14653
German (161) 161
French (108) 108
Japanese (92) 92
Spanish (75) 75
Italian (31) 31
Danish (30) 30
Polish (27) 27
Croatian (23) 23
Russian (22) 22
Swedish (21) 21
Turkish (20) 20
Hungarian (16) 16
Norwegian (16) 16
Czech (15) 15
Portuguese (15) 15
Chinese (12) 12
Korean (7) 7
Dutch (6) 6
Finnish (5) 5
Slovak (4) 4
Hebrew (3) 3
Lithuanian (3) 3
Romanian (3) 3
Bulgarian (2) 2
Arabic (1) 1
Belarusian (1) 1
Icelandic (1) 1
Serbian (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Osteoporosis International, ISSN 0937-941X, 1/2013, Volume 24, Issue 1, pp. 23 - 57
Guidance is provided in a European setting on the assessment and treatment of postmenopausal women at risk of fractures due to osteoporosis.The International... 
Treatment of osteoporosis | FRAX | Health economics | Medicine & Public Health | Orthopedics | Gynecology | Fracture risk assessment | Rheumatology | Bone mineral density | Endocrinology | Diagnosis of osteoporosis | INCREASED CARDIOVASCULAR RISKS | VITAMIN-D SUPPLEMENTATION | BONE-MINERAL DENSITY | HORMONE REPLACEMENT THERAPY | FOR-CLINICAL-DENSITOMETRY | INTRAVENOUS ZOLEDRONIC ACID | VERTEBRAL FRACTURE RISK | ENDOCRINOLOGY & METABOLISM | X-RAY ABSORPTIOMETRY | PRIOR BISPHOSPHONATE THERAPY | ESTROGEN PLUS PROGESTIN | Osteoporosis, Postmenopausal - epidemiology | Risk Assessment - methods | Age Distribution | Osteoporosis, Postmenopausal - diagnosis | Bone Density - physiology | Humans | Middle Aged | Osteoporotic Fractures - prevention & control | Osteoporosis, Postmenopausal - complications | Bone Density Conservation Agents - therapeutic use | Europe - epidemiology | Hip Fractures - etiology | Biomarkers - blood | Drug Monitoring - methods | Hip Fractures - epidemiology | Osteoporotic Fractures - etiology | Absorptiometry, Photon | Osteoporosis, Postmenopausal - drug therapy | Medication Adherence | Hip Fractures - prevention & control | Aged, 80 and over | Female | Aged | Osteoporotic Fractures - epidemiology | Practice guidelines (Medicine) | Osteoporosis | Care and treatment | Postmenopausal women | Diagnosis | Health aspects | Position Paper
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 03/2011, Volume 26, Issue 3, pp. 503 - 511
Clinical data suggest concomitant therapy with bisphosphonates and parathyroid hormone (PTH) may blunt the anabolic effect of PTH; rodent models suggest that... 
ZOLEDRONIC ACID | INFUSION | TERIPARATIDE | BISPHOSPHONATE | OSTEOPOROSIS | Bisphosphonate | teriparatide | infusion | osteoporosis | zoledronic acid | BONE-MINERAL DENSITY | PARATHYROID-HORMONE 1-34 | ALENDRONATE | WOMEN | FRACTURE | BISPHOSPHONATES | THERAPY | CANCELLOUS BONE | MASS | ENDOCRINOLOGY & METABOLISM | PROXIMAL FEMUR | Collagen Type I - blood | Peptides - blood | Injections, Intravenous | Teriparatide - therapeutic use | Bone Density - physiology | Follow-Up Studies | Humans | Middle Aged | Osteoporosis, Postmenopausal - complications | Imidazoles - administration & dosage | Osteoporotic Fractures - drug therapy | Bone Remodeling - physiology | Injections, Subcutaneous | Peptide Fragments - blood | Diphosphonates - therapeutic use | Female | Imidazoles - therapeutic use | Drug Therapy, Combination | Osteoporotic Fractures - physiopathology | Diphosphonates - adverse effects | Biomarkers - metabolism | Bone Density Conservation Agents - adverse effects | Teriparatide - administration & dosage | Imidazoles - adverse effects | Bone Density Conservation Agents - therapeutic use | Diphosphonates - administration & dosage | Procollagen - blood | Bone Density Conservation Agents - administration & dosage | Osteoporosis, Postmenopausal - drug therapy | Osteoporosis, Postmenopausal - blood | Osteoporotic Fractures - complications | Least-Squares Analysis | Osteoporosis, Postmenopausal - physiopathology | Teriparatide - adverse effects | Aged | Osteoporotic Fractures - blood
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2010, Volume 362, Issue 8, pp. 686 - 696
Women between 59 and 80 years of age with a bone mineral density T score of –2.5 or less at the femoral neck or spine received the selective estrogen-receptor... 
MEDICINE, GENERAL & INTERNAL | VERTEBRAL FRACTURES | NONVERTEBRAL FRACTURES | CARDIOVASCULAR EVENTS | RALOXIFENE | TAMOXIFEN | RANDOMIZED-TRIAL | FOLLOW-UP | RISK | BREAST-CANCER PREVENTION | ESTROGEN PLUS PROGESTIN | Humans | Middle Aged | Osteoporosis, Postmenopausal - complications | Fractures, Bone - epidemiology | Pyrrolidines - adverse effects | Selective Estrogen Receptor Modulators - adverse effects | Tetrahydronaphthalenes - therapeutic use | Coronary Disease - epidemiology | Risk | Receptors, Estrogen - analysis | Tetrahydronaphthalenes - adverse effects | Pyrrolidines - therapeutic use | Spinal Fractures - prevention & control | Selective Estrogen Receptor Modulators - therapeutic use | Female | Stroke - epidemiology | Venous Thromboembolism - epidemiology | Breast Neoplasms - epidemiology | Stroke - prevention & control | Bone Density Conservation Agents - adverse effects | Spinal Fractures - epidemiology | Bone Density Conservation Agents - therapeutic use | Osteoporosis, Postmenopausal - drug therapy | Breast Neoplasms - prevention & control | Bone Density - drug effects | Coronary Disease - prevention & control | Venous Thromboembolism - chemically induced | Aged | Fractures, Bone - prevention & control | Osteoporosis | Receptors | Usage | Estrogen | Causes of | Postmenopausal women | Breast cancer | Venous thrombosis | Cardiovascular diseases | Health aspects | Risk factors | Bones | Bone density | Cancer
Journal Article